These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2721034)

  • 1. Augmentation of natural cytotoxicity by leucine enkephalin in cultured peripheral blood mononuclear cells from patients infected with human immunodeficiency virus.
    Oleson D; Grierson H; Goldsmith J; Purtilo DT; Johnson D
    Clin Immunol Immunopathol; 1989 Jun; 51(3):386-95. PubMed ID: 2721034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of human natural cytotoxicity by enkephalins and selective opiate agonists.
    Oleson DR; Johnson DR
    Brain Behav Immun; 1988 Sep; 2(3):171-86. PubMed ID: 2907409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of Leu-enkephalin and alpha-interferon in modulation of NK-activity of human peripheral blood lymphocytes.
    Gabrilovac J; Martin-Kleiner I; Ikić-Sutlić M; Osmak M
    Ann N Y Acad Sci; 1992 Apr; 650():140-5. PubMed ID: 1605472
    [No Abstract]   [Full Text] [Related]  

  • 4. Neuroimmunomodulation with enkephalins: in vitro enhancement of natural killer cell activity in peripheral blood lymphocytes from cancer patients.
    Faith RE; Liang HJ; Plotnikoff NP; Murgo AJ; Nimeh NF
    Nat Immun Cell Growth Regul; 1987; 6(2):88-98. PubMed ID: 3600678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells.
    Thiele DL; Lipsky PE
    J Immunol; 1985 Feb; 134(2):786-93. PubMed ID: 3965574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I.
    Nair MP; Schwartz SA
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):969-79. PubMed ID: 9449529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo bidirectional regulation of mouse natural killer (NK) cell cytotoxic activities by Leu-enkephalin: reversibility by naloxone.
    Gabrilovac J; Antica M; Osmak M
    Life Sci; 1992; 50(1):29-37. PubMed ID: 1728722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroimmunomodulation with enkephalins: enhancement of human natural killer (NK) cell activity in vitro.
    Faith RE; Liang HJ; Murgo AJ; Plotnikoff NP
    Clin Immunol Immunopathol; 1984 Jun; 31(3):412-8. PubMed ID: 6713744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver.
    Wiltrout RH; Mathieson BJ; Talmadge JE; Reynolds CW; Zhang SR; Herberman RB; Ortaldo JR
    J Exp Med; 1984 Nov; 160(5):1431-49. PubMed ID: 6491601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analyses of natural killer cells in macaques infected with neurovirulent simian immunodeficiency virus.
    Shieh TM; Carter DL; Blosser RL; Mankowski JL; Zink MC; Clements JE
    J Neurovirol; 2001 Feb; 7(1):11-24. PubMed ID: 11519478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of natural cytotoxicity by beta-endorphin.
    Mathews PM; Froelich CJ; Sibbitt WL; Bankhurst AD
    J Immunol; 1983 Apr; 130(4):1658-62. PubMed ID: 6300232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells.
    Mandler RN; Biddison WE; Mandler R; Serrate SA
    J Immunol; 1986 Feb; 136(3):934-9. PubMed ID: 2934481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL 2.
    Bonavida B; Katz J; Gottlieb M
    J Immunol; 1986 Aug; 137(4):1157-63. PubMed ID: 3488345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphokine-activated cytotoxicity in peripheral blood mononuclear cells of severely immunocompromised HIV-infected patients.
    Forthal DN; Landucci G; Robinson WE
    Scand J Immunol; 1997 Jan; 45(1):91-5. PubMed ID: 9010505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of the enkephalins on natural killer cytotoxicity].
    Lin J
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1990 Dec; 12(6):457-60. PubMed ID: 2151267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of natural killer (NK) cell subsets defined by the expression of two novel surface antigens (EB6 and GL183) in AIDS and AIDS-related conditions.
    Cauda R; Goletti D; Lucia MB; Tumbarello M; Rumi C; Orengo AM; Moretta A
    Clin Immunol Immunopathol; 1994 Mar; 70(3):198-205. PubMed ID: 8313656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cell infection and inactivation in vitro by the human immunodeficiency virus.
    Robinson WE; Mitchell WM; Chambers WH; Schuffman SS; Montefiori DC; Oeltmann TN
    Hum Pathol; 1988 May; 19(5):535-40. PubMed ID: 3286479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD; Mitsuyasu R; Gottlieb MS; Lebow LT; Bonavida B
    J Immunol; 1987 Jul; 139(1):55-60. PubMed ID: 3584988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.